Indefinite Delivery Contract N0017819D7785

The federal contract IDV awarded to Hyperion Biotechnology, Inc. by the Naval Sea Systems Command (NAVSEA) is part of the SeaPort Next Generation (SeaPort-NXG) program, a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle for providing engineering, technical, and programmatic support services to the Department of the Navy. The contract has a ceiling value of $500 and a period of performance through January 1, 2029. Hyperion Biotechnology, a self-certified small disadvantaged, woman-owned, veteran-owned, and service-disabled veteran-owned business, is providing specialized environmental testing, analysis, and remediation services, with a focus on Legionella testing for the Department of Veterans Affairs (VA) medical facilities nationwide. The company has secured several significant IDIQ and Blanket Purchase Agreement contracts with the VA, ranging from $340,832.60 to $2 million, to deliver on-demand Legionella testing and environmental monitoring services across multiple VHA health care systems. These contracts are frequently set aside for service-disabled veteran-owned small businesses (SDVOSB) or total small business designations.

The original SeaPort-NXG solicitation, issued by NAVSEA, sought proposals from offerors demonstrating experience in one of twenty-three functional areas supporting the Navy within the past five years. Awards were made based on initial proposals without discussions, under a North American Industry Classification System code of 541330 for professional, scientific, and technical services. The small business size standard is average annual revenue of $38.5 million. The SeaPort-NXG program involves over 3,000 prime contractors and covers a wide range of engineering, logistics, and information technology support services for the Navy and other Department of Defense components.